SMOC1 and amyloidosis: While further study is required to determine the mechanistic role of SMOC1 in AD, preliminary results from an independent group suggest that it may be neuroprotective as SMOC1 overexpression in a transgenic mouse model of AD significantly reduced amyloid plaque count without any accompanying neurotoxicity [4].